| OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale |
Globe Newswire |
05/11 |
07:30 |
| Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/11 |
07:30 |
| Transaction in Own Shares |
Globe Newswire |
05/11 |
07:20 |
| Encore Capital Group, Inc. Announces Proposed Senior Secured Notes Offering |
Globe Newswire |
05/11 |
07:17 |
| Tapbit Enhances Platform Reliability with Advanced Asset Protection and Transparency Framework |
Globe Newswire |
05/11 |
07:16 |
| Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up |
Globe Newswire |
05/11 |
07:05 |
| IREN Announces Proposed Convertible Notes Offering |
Globe Newswire |
05/11 |
07:00 |
| Village Farms Reports Q1 2026 Results Driven by Record International Export Sales |
Globe Newswire |
05/11 |
07:00 |
| OTC Markets Group Welcomes Evolve Royalties Ltd. to OTCQX |
Globe Newswire |
05/11 |
07:00 |
| Hain Celestial Reports Fiscal Third Quarter 2026 Financial Results |
Globe Newswire |
05/11 |
07:00 |
| Keel Infrastructure Reports First Quarter 2026 Results |
Globe Newswire |
05/11 |
07:00 |
| Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program |
Globe Newswire |
05/11 |
07:00 |
| Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago |
Globe Newswire |
05/11 |
07:00 |
| Multi Ways Holdings Reports Fiscal Year 2025 Results: Revenue Grows 44% to $44.8 Million |
Globe Newswire |
05/11 |
07:00 |
| Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab) |
Globe Newswire |
05/11 |
07:00 |
| Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update |
Globe Newswire |
05/11 |
07:00 |
| MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing |
Globe Newswire |
05/11 |
07:00 |
| RoboStrategy, Inc. Lists on NASDAQ Under Ticker “BOT”, Enabling Investors to Access a Portfolio of Robotics and Physical AI Companies in a Single Stock |
Globe Newswire |
05/11 |
07:00 |
| Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes |
Globe Newswire |
05/11 |
07:00 |
| Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China |
Globe Newswire |
05/11 |
07:00 |
| OTC Markets Group Welcomes Grande Portage Resources Ltd. to OTCQX |
Globe Newswire |
05/11 |
07:00 |
| Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/11 |
07:00 |
| 4basebio Launches Enzymatic ssDNA Platform |
Globe Newswire |
05/11 |
07:00 |
| ARKO Petroleum Corp. Reports First Quarter 2026 Results |
Globe Newswire |
05/11 |
07:00 |
| SailPoint Launches Agentic Fabric to Secure AI Identities Across the Enterprise |
Globe Newswire |
05/11 |
07:00 |
